Publication

The influences of hyperprolactinaemia and obesity on cardiovascular risk markers: effects of cabergoline therapy

Journal Paper/Review - Dec 1, 2006

Units
PubMed
Doi

Citation
Schmid C, Brändle M. The influences of hyperprolactinaemia and obesity on cardiovascular risk markers: effects of cabergoline therapy. Clinical endocrinology 2006; 65:827-8.
Type
Journal Paper/Review (English)
Journal
Clinical endocrinology 2006; 65
Publication Date
Dec 1, 2006
Issn Print
0300-0664
Pages
827-8
Brief description/objective